UX701
UX701-CL301
Phase 2 gene_therapy active
Quick answer
UX701 for Wilson Disease is a Phase 2 program (gene_therapy) at Ultragenyx UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx UK Limited
- Indication
- Wilson Disease
- Phase
- Phase 2
- Modality
- gene_therapy
- Status
- active